Renalytix Share Discussion Threads

[74tom] 25/11/2020 15:21

At last!!

RENX get a 10% royalty on any sales revenue, there were a lot of different prices quoted a few months back ranging from $40 up to $100+... either way, the timing is very good with the vaccine rollout about to start, and with Bio Techne able to manufacture 10m a month straight off there should be considerable benefit.

If they sell 10m tests over the course of the next 6 months at $40 per test that would bring in $40m of profit for RENX. Huge numbers are possible here.

[mad foetus] 25/11/2020 15:00

I've no idea what the margin for RENX is on each test or how long they will be needed for, but for a company with limited current revenues a few months of an extra few million could be very significant. Plus, our profile is raised ready for the next news

[nimbo1] 25/11/2020 14:48

its a bit of a shame this didn't happen 3 months ago - it probably would have doubled the share price in the US but things take time!

[mad foetus] 25/11/2020 14:47

At US healthcare prices too...

[mr roper] 25/11/2020 14:46

Well, if bio techno can start shipping 10m units of the test a month that’ll make a monstrous difference to revenues here.

[nimbo1] 25/11/2020 14:44

weird world where US up 30% and aim 6%... go figure. However the US did fall 10% yesterday where as aim was flat.

[mr roper] 25/11/2020 14:43

Almost like they knew that 8m quid line of stock was about to be shifted, then the news came...I love happy coincidences.

[nw99] 25/11/2020 14:38

Wakes wakey

[montynj] 25/11/2020 14:32

US quote up 34%...Mms here are sleeping

[montynj] 25/11/2020 13:32

https://finance.yahoo.com/news/kantaro-receives-fda-emergency-authorization-123000381.html

[montynj] 25/11/2020 13:30

https://finance.yahoo.com/news/renalytixai-reports-financial-results-first-120000260.html

[cambridgedon] 25/11/2020 13:29

Added!
CD

[busterdog2] 25/11/2020 13:13

From 38mins...

[montynj] 25/11/2020 13:10

In USA up 17% pre market

[cambridgedon] 25/11/2020 13:01

Kantaro Receives FDA Emergency Use Authorization for Semi-Quantitative COVID-19 Antibody Test Kit that Detects the Presence and Level of SARS-CoV-2 IgG Antibodies.
Just out!
CD

[nw99] 25/11/2020 10:27

This trades in the USA expect it move higher later

[mr roper] 25/11/2020 09:29

For a business update the Stifel call last week was pretty good. Lots in the pipeline here. Patience is the key.

[wan] 25/11/2020 08:05

There is nothing new per se, but some interesting detail if you scroll further down for the Operational Update and Financial Results for the Three Months Ended September 30, 2020

[74tom] 25/11/2020 07:59

Indeed, if they’re going to release quarterly commentary like that it needs to be accompanied by a secondary release with a business / trading update! Nobody is invested to read about cash burn... we would like to know how the KidneyIntelX roll out is going / what else is going on.

[2theduke] 25/11/2020 07:46

Well I guess some people knew about the extremely monotone financial trading release.
I guess there most be some serious us based regulatory reasons for writing such a downbeat commentary.

[welshborderer] 25/11/2020 00:47

London South East managed to make it look like £10.7 million traded

[mr roper] 24/11/2020 17:53

Big vol day, 8m+ quids worth shifted in 3 trades.